Modification of chitosan for simultaneous antioxidant and antibacterial functions by CHEN FEI
  
MODIFICATION OF CHITOSAN FOR SIMULTANEOUS 















NATIONAL UNIVERSITY OF SINGAPORE 
2009 
  
MODIFICATION OF CHITOSAN FOR SIMULTANEOUS 













A THESIS SUBMITTED  
FOR THE DEGREE OF MASTER OF ENGINEERING  
DEPARTMENT OF CHEMICAL AND BIOMOLECULAR 
ENGINEERING  




Studying for a degree is a huge process that evolves over time and involves many role 
players, some of whom do not even realize the part they have played. I owe a huge 
debt to my supervisor Prof. Neoh Koon Gee, who gave me confidence and guidance 
to persist in my research works. I also want to express my thanks to my colleagues, Dr. 
Shi Zhilong, Chua Poh Hui, Tan Lihan, Zhang Fan and Lim Siew Lay. Discussing and 
talking with them have always inspired me on my research work. 
 




TABLE OF CONTENTS 
ACKNOWLEDGEMENT i 
TABLE OF CONTENTS ii 
SUMMARY vi 
NOMENCLATURE viii 
LIST OF FIGURES ix 
LIST OF SCHEMES x 
LIST OF TABLES xi 
1 Introduction 1 
2 Literature review 5 
2.1 Chitosan 5 
2.1.1 Sources of chitosan 5 
2.1.2 Chemistry of chitosan 7 
2.1.3 Biological properties of chitosan 9 
2.1.4 Applications of chitosan 11 
2.2 Ascorbic acid 14 
2.3 Essential oils 15 
2.3.1 Major components of essential oils 15 
2.3.2 Antibacterial activity of essential oils 16 
2.3.3 Mode of antibacterial action of essential oils 17 
2.4 Derivatization methods 19 
2.4.1 Derivatization of chitosan 19 
2.4.2 Derivatization of ascorbic acid 21 
2.4.3 Formylation of essential oils 22 
3 Antioxidant and antibacterial abilities of chitosan ascorbate 24 
 iii
3.1 Introduction 24 
3.2 Experimental 26 
3.2.1 Materials 26 
3.2.2 Preparation of chitosan ascorbate 26 
3.2.3 Characterization of chitosan ascorbate 26 
3.2.4 Free radical scavenging ability of chitosan ascorbate 27 
3.2.5 Antibacterial test of chitosan ascorbate 27 
3.2.6 Cytotoxicity assay of chitosan ascorbate 28 
3.3 Results and discussions 30 
3.3.1 Characterization of chitosan ascorbate 30 
3.3.2 Free radical scavenging ability of chitosan ascorbate 33 
3.3.3 Antibacterial test of chitosan ascorbate 34 
3.3.4 Cytotoxicity assay of chitosan ascorbate 35 
3.4 Conclusion 37 
4 Antioxidant and antibacterial activities of eugenol grafted chitosan nanoparticles 
  38 
4.1 Introduction 38 
4.2 Experimental 40 
4.2.1 Materials 40 
4.2.2 Synthesis of eugenol aldehyde 40 
4.2.3 Preparation of chitosan nanoparticles 40 
4.2.4 Grafting of eugenol on chitosan and chitosan nanoparticles through the 
Schiff base reaction 41 
4.2.5 Characterization techniques 41 
4.2.6 Scavenging ability of eugenol grafted chitosan derivatives 42 
 iv
4.2.7 Determination of antibacterial activity of eugenol grafted chitosan 
derivatives 42 
4.2.8 In vitro cytotoxicity of eugenol grafted chitosan derivatives 42 
4.3 Results and discussions 44 
4.3.1 Synthesis of eugenol aldehyde 44 
4.3.2 Characterization of eugenol grafted chitosan derivatives 46 
4.3.3 Free radical scavenging ability of eugenol grafted chitosan derivatives 
  51 
4.3.4 Antibacterial effects of eugenol grafted chitosan derivatives 52 
4.3.5 Cytotoxicity assay of eugenol grafted chitosan derivatives 54 
4.4 Conclusion 57 
5 Antioxidant and antibacterial activities of carvacrol grafted chitosan 
nanoparticles 58 
5.1 Introduction 58 
5.2 Experimental 59 
5.2.1 Materials 59 
5.2.2 Synthesis of carvacrol aldehyde 59 
5.2.3 Preparation of chitosan nanoparticles 60 
5.2.4 Grafting of carvacrol on chitosan nanoparticles through the Schiff base 
reaction 60 
5.2.5 Characterization techniques 60 
5.2.6 Scavenging ability of carvacrol grafted chitosan nanoparticles 60 
5.2.7 Determination of antibacterial activity of carvacrol grafted chitosan 
nanoparticles 61 
5.2.8 In vitro cytotoxicity of carvacrol grafted chitosan nanoparticles 61 
 v
5.3 Results and discussions 62 
5.3.1 Synthesis of carvacrol aldehyde 62 
5.3.2 Characterization of carvacrol grafted chitosan nanoparticles 63 
5.3.3 Free radical scavenging ability of carvacrol grafted chitosan 
nanoparticles 67 
5.3.4 Antibacterial effects of carvacrol grafted chitosan nanoparticles 68 
5.3.5 Cytotoxicity assay of carvacrol grafted chitosan nanoparticles 69 
5.4 Comparative study of carvacrol grafted chitosan nanoparticles and eugenol 
grafted chitosan nanoparticles 72 
5.4.1 Degree of grafting of essential oil components 72 
5.4.2 Antibacterial activity 72 
5.4.3 Antioxidant activity 73 
5.4.4 Cytotoxicity 73 
5.5 Conclusion 75 
6 Conclusion and recommendations 76 
6.1 Conclusion 76 
6.2 Recommendations 79 




Polysaccharides can be modified with various molecules bearing intriguing biological 
properties. The modified polysaccharides retain the bulk properties with additional 
biological activities. In this thesis, three small molecules from natural sources, namely, 
ascorbic acid, eugenol, and carvacrol were grafted via chemical reactions to chitosan, 
a popular polysaccharide. The main focus of this thesis is on the subsequent biological 
assays of the developed chitosan derivatives. 
 
Firstly, ascorbic acid, a commonly used antioxidant, was grafted onto chitosan to 
yield chitosan ascorbate. A series of characterization techniques and biological assays 
were applied to identify the modified product and as well as its biological properties. 
 
Next, aldehyde groups were introduced in eugenol and the modified eugenol was 
reacted with chitosan and chitosan nanoparticles (CH NPs) through the Schiff base 
reaction. The eugenol grafted chitosan (CHEU) and eugenol grafted chitosan 
nanoparticles (CHEU NPs) were then characterized by X-ray photoelectron 
spectroscopy (XPS) and transmission electron microscopy (TEM). CHEU and CHEU 
NPs were then assayed to assess their free radical scavenging and antibacterial 
abilities. Their cytotoxicity towards 3T3 mouse fibroblasts was also investigated.  
 
The modification strategy was then extended to another essential oil component, 
carvacrol. The formylated carvacrol was grafted onto the CH NPs. Similar 
characterization techniques and biological assays were then used to investigate the 
carvacrol grafted chitosan nanoparticles (CHCA NPs). Finally, a comparative study 
 vii
was made between CHCA NPs and CHEU NPs to establish their suitability for 
potential biomedical applications. 
 
In conclusion, the chitosan was successfully modified with ascorbic acid, eugenol or 
carvacrol either in the power form (CHAA and CHEU) or in the nanoparticle form 
(CHEU NPs and CHCA NPs). these modified chitosan powders and nanoparticles 
have simultaneous antioxidant and antibacterial functions which may potentially be 
useful in biomedical and food packaging applications. 
 viii
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Reactive oxygen species (ROS) and bacterial infections are two threats which the 
human body, animals and even food are continuously exposed to.  ROS may lead to 
oxidative stress, which has been considered to be related to aging, many pathological 
disorders, and even cancer (Hermans et al., 2007, Shetty et al., 2008, Reddy et al., 
2008). Food quality also deteriorates when exposed to ROS (Srinivasa and 
Tharanathan, 2007).  On the other hand, infections will result from bacterial 
attachment and biofilm formation on surfaces in daily situations. Thus, materials 
possessing antioxidant and antibacterial activities can be expected to have good 
potential for applications. Of particular interest would be such materials developed 
from natural sources. Materials developed from natural sources have played such an 
important role in biomedical science because they are usually believed to be 
biocompatible, eco-friendly and low cost. They are usually studied by two means: in 
bulk form where they are modified to cater for special purposes; or as a functional 
group grafted on to the bulk materials to confer them with additional properties.  
 
Three natural materials, chitosan (CH), essential oils (EOs) and L-ascorbic acid (AA), 
have been selected for investigation in the current work because of their interesting 
properties. CH is prepared from the chitin which is harvested from shrimp shells, crab 
or fungal mycelia. CH can be easily made into nanoparticles, membranes and fibers. 
With their versatile forms, CH and its derivatives are applied in drug delivery, wound 
dressing and food packaging due to their biocompatible, antimicrobial and 
pharmaceutical properties (Rabea, et al., 2003, Srinivasan and Tharanathan, 2007, 
Kumar, 2000). Depending on the purposes of the various applications, different 
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modification strategies were adopted. The basic principle for chitosan modification is 
to make use of either its hydroxyl groups at the C-3 and C-6 positions, or its amine 
groups (Rinaudo, 2008).  
 
The richest natural sources of AA are fruits and vegetables. AA is very popular for its 
antioxidant property. It can also be modified and manipulated to form complex 
molecules for further applications. AA, can be alkylated and acylated under basic and 
acidic conditions, oxidized or reduced, and also be modified to form acetal and ketal 
derivatives. 
 
EOs, extracted from natural plants, are known to possess medicinal properties, 
antimicrobial activity and even antioxidant property. The phenolic part of their 
structures is believed to confer their intriguing biological properties. On the other 
hand, their potential applications have been limited by their cytotoxicity to human 
cells and tissues. So there is an incentive to find a breakthrough to allow the 
utilization of their biological properties while concomitantly reducing the risk of 
damaging the normal cells and tissues.  
 
In this work, the objective is to develop biomaterials based on CH as the bulk material, 
and modified with AA and EOs. The EOs and AA modified chitosan will possess 
both antioxidant and antibacterial activities which may be potentially useful for 
biomedical and food packaging applications. With this purpose in mind, a more 
detailed discussion of the properties of these three materials and the previous works 




 In Chapter 3, the modification technique used to prepare chitosan ascorbate (CHAA) 
through the Schiff base reaction is presented. The CHAA was characterized by X-ray 
photoelectron spectroscopy (XPS), and its biological assays showed that after 
modification, CHAA possessed antioxidant properties while its antibacterial efficacy 
was slightly lower compared to that of chitosan. 
 
Essential oils contain a large number of aromatic components, which may be utilized 
for functionalization purposes via appropriate strategies. Since the aromatic aldehyde 
formed by Schiff base reaction is more stable than CHAA, eugenol, one of the 
essential oil components, was grafted onto CH and chitosan nanoparticles (CH NPs) 
through Schiff base reaction as described in Chapter 4. The biological assays showed 
that the eugenol grafted chitosan (CHEU) and eugenol grafted chitosan nanoparticles 
(CHEU NPs) were conferred with antioxidant and antibacterial abilities, and both of 
them showed lower cytotoxicity than free eugenol. CHEU NPs showed even higher 
biological activity efficacy due to their nanoparticulate form compared to CHEU. 
 
The modification techniques were then extended to another essential oil component, 
carvacrol. In Chapter 5, the process to introduce aldehyde group into carvacrol and 
the subsequent grafting of carvacrol aldehyde onto CH NPs was describes. The 
carvacrol grafted chitosan nanoparticles (CHCA NPs) were then characterized by 
XPS and transmission electron microscopy (TEM). The biological assay showed that 
the CHCA NPs possessed both antioxidant and antibacterial activities. The 
cytotoxicity of CHCA NPs is significantly lower than that of pure carvacrol. The 
CHCA NPs were finally compared with CHEU NPs with respect to their degrees of 




Finally, Chapter 6 gives the overall conclusion of the present work and the 
recommendations for the future work. Though the properties of chitosan have been 
successfully improved via chemical modifications, much work can still be done to 
further enhance its use in clinical and industrial applications.    
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2 Literature review 
This literature review focuses on the applications of three types of natural materials in 
the domain of biomaterials: chitosan, EOs and AA. Their antioxidant and 
antimicrobial mechanisms, and the modification strategies which are applicable to 
these three materials are reviewed. 
 
2.1 Chitosan 
Chitin, or poly (N-acetyl-1, 4-β-D-glucopyranosamine) is the most abundant natural 
polysaccharide after cellulose. It may be regarded as cellulose with the hydroxyl 
group at the C-2 position replaced by an acetamido group. Chitin can be N-
deacetylated to obtain chitosan. The structures of cellulose, chitin and chitosan are 
shown in Scheme 2-1. The following paragraph will focus on the chemistry, 
properties and applications of chitosan. 
 
2.1.1 Sources of chitosan 
Chitin can be obtained from shrimp shells or crab and fungal mycelia (Kumar, 2000). 
The N-deacetylation of chitin to obtain chitosan is usually realized by alkali treatment 
as shown in Scheme 2-2. The alkali treatment can result in chitosan with different 
degrees of deacetylation, depending on the alkali concentration, treatment duration 
and temperature. According to Wu et al (1978), deacetylation of chitosan could reach 
around 70% (degree of deacetylation, DD) in the first hour of alkali treatment in 50% 
NaOH solution at 100 ºC, but it would take 5 hours to reach 80%. Further treatment 
showed no increase of DD value.  Domard et al. (1983) and Mima et al. (1983) 
Chapter 2 
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proved their strategies to prepare highly and even fully deacetylated chitosan without 
much degradation of the chitosan molecular chains by repeating the alkali treatment 
several times. Therefore, the preparation process of chitosan determines the resultant 

























































Scheme 2-2 Preparation process of chitosan from chitin. 
 
2.1.2 Chemistry of chitosan 
Investigations of chitosan have been concerned with its preparation from chitin and its 
resultant degree of deacetylation and molecular weight, as well as their effects on its 
solution properties, since these chemical properties may significantly affect the 
biological properties and applications of chitosan and its derivatives. The effects and 
characterizations of such properties (DD, molecular weight and solubility) are briefly 
discussed below.  
 
(1) Degree of N-acetylation and degree of deacetylation  
Takahashi et al (2008) and Chiu et al (2007) reported that a higher DD would lead to 
a higher antibacterial efficacy against Staphylococcus aureus (S. aureus) and 
Escherichia coli (E. coli). According to Je et al. (2006), chitosan with a DD of 90% 
has a higher scavenging reactive oxygen species (ROS) efficacy compared to those 
with DDs of 75% and 50%.  
 
Degree of N-acetylation (DA) is usually defined as the ratio of 2-acetamido-2-deoxy-
D-glucopyranose to 2-amino-2-deoxy-D-glucopyranose structural units.  On the other 
hand, another term DD, which is defined as the proportion of nitrogen which is in the 
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form of amine groups, is more commonly used. DD can be determined by methods 
including nuclear magnetic resonance (NMR), ultraviolet-visible spectroscopy (UV), 
infrared spectroscopy (IR), circular dichroism (CD), colloid titration, etc (Miya et al., 
1980, Baxter et al., 1992, Rinaudo etc., 1992, Muzzarelli and Rocchetti, 1985). So far, 
the most reliable method seems to be 1H NMR (Rinaudo, 2006). 
 
(2) Molecular weight 
The molecular weight of chitosan affects the antimicrobial ability (Guo et al., 2008, 
Seyfarth et al., 2007, Tsai et al., 2006), drug delivery behavior (Zhou et al., 2008, 
Gupta and Jabrail, 2008), hemostasis (Yang et al., 2008), as well as the antioxidant 
ability  of chitosan and its derivatives (Kim and Thomas, 2007, Je et al., 2004). Thus, 
molecular weight is another important property of chitosan. The molecular weight 
distribution can be determined by high performance liquid chromatography (HPLC) 
(Wu, 1988). The term average molecular weight is often used and it can be simply 
and rapidly determined by viscometry using the Mark-Houwink equation (Kumar, 
2000). The Mark-Houwink equation is expressed as: 
[ ] KM αη =  
Where K and α have been determined in 0.1 M acetic acid and 0.2 M sodium chloride 
solution: K=1.81× 10-3 and α=0.93. η is the intrinsic viscosity of chitosan solution 
and M is the average molecular weights. (Kumar, 2000) 
 
(3) Solubility 
When the degree of deacetylation of chitin reaches about 50% , it becomes soluble in 
aqueous acidic solution and is called chitosan (Rinaudo, 2006). Chitosan in acidic 
media becomes a polyelectrolyte because of the protonation of the amine (–NH2) 
Chapter 2 
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groups. The degree of protonation increases progressively, in tandem with the 
progressive solubilization of chitosan. Complete solubilization is obtained when the 
degree of protonation exceeds 50% and the stoichiometric ratio ([AcOH]/[Chit-NH2]) 
is 0.6 (Rinaudo et al., 1999). The solubility limits the applications of chitosan, thus 
various modification techniques and derivatives have been developed to improve its 
solubility. Copolymerization of maleic acid sodium onto hydroxypropyl chitosan and 
carboxyethyl chitosan sodium yielded the water-soluble chitosan derivatives with 
antioxidant activity (Xie et al., 2001) and antibacterial activity (Xie et al., 2002).  
 
2.1.3 Biological properties of chitosan 
Chitosan is a non-toxic, biocompatible, and biodegradable amino polysaccharide with 
interesting biological, physical, and pharmacological properties. It has notable 
bioactivities including promotion of wound healing hemostatic activity, immunity 
enhancement, hypolipidemic activity, mucoadhesion, eliciting biological responses, 
and antimicrobial activity. Chitosan is also promising as a support polymer for drug 
delivery, gene therapy, cell culture, and tissue engineering. In particular, the 
antimicrobial activity of chitosan and its derivatives against different groups of 
microorganisms, such as bacteria and fungi, have received considerable attention in 
recent years (Kumar, 2000, Hirano, 1999). The antimicrobial and antioxidant 
activities of chitosan and its derivatives are elaborated below. 
 
(1) Antimicrobial activity of chitosan and its derivatives 
Chitosan has been shown to be fungicidal against several fungi (Table 2-1) (Liu et al., 
2001). This antifungal property makes chitosan popular in food industry applications 
such as food wraps (Jiang and Li, 2001) and food additives (Fang et al., 1994). 
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Chitosan also inhibits the growth of various bacteria (Table 2-1) (Liu et al., 2001). 
However, chitosan is insoluble in most solvents except dilute organic acids such as 
acetic acid and formic acid. Thus, various chitosan derivatives were developed to 
satisfy different applications without the loss of antibacterial activity.  
 
Table 2-1 MICs of chitosan against bacteria and fungi in vitro. 
 
Bacteria MICa (ppm) Fungi MIC (ppm) 
Agrobacterium tumefaciens 100 Botrytis cinerea 10 
Bacillus cereus 1000 Fusarium oxysporum 100 
Corynebacterium michiganense 10 Drechslera sorokina 10 
Erwinia sp. 500 Micronectriella nivalis 10 
Erwinia carotovora subsp. 200 Piricularia oryzae 5000 
Escherichia coli (E. coli) 20 Rhizoctonia solani 1000 
Klebsiella pneumoniae 700 Trichophyton equinum 2500 
Micrococcus luteus 20   
Pseudomonas fluorescens 500   
Staphylococcus aureus (S. aureus) 20   
Xanthomonas campestris 500   
a MIC = minimum growth inhibitory concentration. 
 
The exact mechanisms of the antimicrobial action of chitosan and its derivatives are 
still unknown (Rabea et al., 2003), but different mechanisms have been proposed. 
Chitosan acts mainly on the outer surface of the bacteria. The positively charged 
amine groups of chitosan interact with the negatively charged microbial cell 
membrane, altering the cell membrane permeability (Chen et al., 1998, Fang et al., 
1994, Jung et al., 1999). Chitosan has also been known to act as a chelating agent 
which selectively binds metals and thus inhibits the production of toxins and 
microbial growth (Cuero et al., 1991). When chitosan is released from the cell wall of 
fungal pathogens by plant host hydrolytic enzymes, it penetrates into the nuclei of the 
fungi and interacts with RNA and protein synthesis (Hadwiger, 1985).  
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(2) Antioxidant activity of chitosan and its derivatives 
Free radicals, which come from ROS, may disturb the “redox homeostasis” of humans, 
causing oxidative stress on human; they may also deteriorate food quality upon 
penetrating food packages. Chitosan and its derivatives have also been evaluated as an 
antioxidant (Yen et al., 2008, Yen et al., 2007) to protect wounds and food from being 
attacked by ROS. The antioxidant activity of chitosan has been reported to depend on 
the preparation source, such as crab shells and Shiitake stipes, as well as its molecular 
weight (Sun et al., 2008, Sun et al., 2007, Koryagin et al., 2006).  Chitosan can be 
conferred with antioxidant activity via different strategies, either by encapsulating 
chitosan with an antioxidant or derivatization of chitosan (Zhang et al., 2008, 
Kosaraju et al., 2006, Guo et al., 2005, Xing et al., 2005b). The antioxidant activity 
mechanism of chitosan is still unknown. Xie et al. (2001) proposed that the amine 
groups of chitosan may contribute to the antioxidant activity of chitosan. However, 
there is also a report on the limited antioxidant activity of chitosan (Zhang et al., 
2008).  
 
2.1.4 Applications of chitosan 
(1) Chitosan nanoparticles 
Chitosan is easily processed into different forms such as films, gels and nanoparticles. 
The nanoparticulate system provides a particular useful platform, demonstrating 
unique properties with potential wide-range therapeutic applications such as drug 
delivery, gene delivery and cancer targeting. Yao et al. (1995) and Kas (1997) 
highlighted the preparation and properties of the chitosan nanoparticulate system. Due 
to the wide interests in the chitosan nanoparticulate system, the preparation methods 
are surveyed here. 
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Ionotropic gelation.  In this method, chitosan is dissolved in acetic acid and then 
added dropwise into different concentrations of tripolyphosphate solution. The 
particles are harvested by centrifugation and washed with Milli-Q water, followed by 
freeze-drying (Kas, 1997, Kumar, 2000, Zhang et al., 2004). This method is the most 
frequently used one. 
 
Solvent evaporation techniques.  In this method, chitosan in an aqueous acetic acid 
solution is added to toluene and sonicated to form a water/oil (W/O) emulsion. 
Glutaraldehyde in toluene is then added and the mixture is stirred at room temperature 
to give cross-linked microspheres. The suspension is centrifuged, followed by 
evaporation of the solvent. The microspheres are obtained after separation, washing 
and drying (Gallo and Hassan, 1988).   
 
Li et al. (1991) modified this solvent evaporation technique and renamed it “Dry-in-
Oil” by evaporating the W/O emulsion system at 50 °C under reduced pressure 
instead of adding of glutaraldehyde as the crosslinker. Pavenetto et al (1995) 
developed a multiphase emulsion method using the solvent evaporation technique by a 
three-step emulsification process: Step 1, aqueous drug solution and oil containing 
stabilizers are combine to form a W/O emulsion; Step 2, the W/O emulsion is then 
dispersed into the polymer solution; Step 3, the system is evaporated under reduced 
pressure.  
 
Precipitation/coacervation method. In this method, sodium sulphate solution is added 
dropwise to chitosan in acetic acid solution with stirring and ultrasonication. The 
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nanoparticles are harvested by centrifugation and washing process (Genta et al., 1995, 
Berthold et al., 1996). 
 
(2) Food packaging 
Packaging is important in post-harvest preservation of fruits, vegetables and 
processed foods to achieve a relatively long shelf-life. Besides protection of food 
from physical change (mechanical damage during transit or storage, loss of 
consistency or crispness, loss of appearance, and sales appeal), the package should 
also have the ability to inhibit microbial infections and oxygen-based deterioration 
(Srinivasa and Tharanathan, 2007). Due to their film-forming ability, antimicrobial 
ability and biodegradability, chitosan and its derivatives have been successfully used 
in food industry as an eco-friendly packaging material.  
 
(3)Wound healing 
Wound healing is the process of repairing injury to the skin and other soft tissues due 
to infections or in the normal aging process of cells (Meddahi et al., 1994). Wound 
healing involves three distinct phases: the inflammatory phase, the proliferative phase, 
and finally the remodeling phase (Calvin, 2000, Klenkler and Sheardown, 2004). The 
inflammatory response begins immediately after the wound happens, followed by the 
accumulation of bacteria and debris which need to be phagocytized or removed 
(Degim, 2008). ROS released by the neutrophils can destroy viable tissues if they are 
not limited. Chitosan can be used via two means in the process of wound healing 
either in the form of wound dressings or in the form of a micro/nanoparticulate system 




Chitosan has been used as wound dressings because it is a natural, biocompatible, 
biodegradable, hemostatic, and anti-infective mucoadhesive polymer in addition to its 
positive charge property, film-forming and gelation characteristics. Chitosan as a 
wound dressing has been shown to affect all stages of wound healing. Its hemostatic 
activity can be seen in the inflammatory phase, and it also regulates the migration of 
neutrophils and macrophages acting on repair processes such as fibroplasias and re-
epithelization, thus accelerating the wound healing process (Borchard and Junginger, 
2001, Ueno et al., 2001). Deng et al (2007) have reported a chitosan-gelation sponge 
wound dressing which possessed antibacterial ability and promoted the wound healing 
process. The recent development in chitosan wound dressing include the 
incorporation a procoagulant (polyphosphate) and an antimicrobial agent (silver) in 
the chitosan dressing to improve hemostatic and antimicrobial properties (Ong et al., 
2008). 
 
Chitosan has also been evaluated as a potential carrier for wound healing growth 
factors in the form of micro- or nanoparticles. Controlled release of growth factor 
from this chitosan microparticulate system has enhanced healing in the wound sites 
(Degim, 2008). 
 
2.2 Ascorbic acid 
AA, also known as Vitamin C, is probably the most celebrated chemical since its 
discovery in 1921 (Arrigoni and De Tullio, 2002). AA belongs to the six-carbon 
lactone family which can be synthesized from glucose in the liver of most mammalian 
species except humans (Padayatty et al., 2003), as humans lack the enzyme 
gulonolactone oxidase, which is essential for the synthesis of 2-keto-l-gulonolactone, 
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the immediate precursor of AA. The DNA encoding for gulonolactone oxidase has 
undergone substantial mutation, leading to the absence of a functional enzyme in 
humans. Therefore, without the ingestion of Vitamin C, a deficiency state with a 
broad spectrum of clinical symptoms will occur in humans. Scurvy, a clinical 
expression of Vitamin C deficiency, is a lethal condition unless appropriately treated 
(Padayatty et al., 2003). 
 
 AA acts as an antioxidant which can efficiently scavenge toxic free radicals and other 
ROS produced in cell metabolism. AA is an electron donor making it a reductant. 
When it acts as a reductant, AA donates two electrons from a double bond between 
the C-2 and C-3. AA is an antioxidant because it prevents other compounds from 
being oxidized by donating its electrons. Thus, AA itself is oxidized in the process 
(Buettner, 1993). 
 
2.3 Essential oils 
EOs are oily aromatic compounds extracted from natural plant materials.  They were 
widely used in the food, dentistry and cosmetic industries because of their 
antibacterial, antifungal and antioxidant properties. 
 
2.3.1 Major components of essential oils 
The methods using for producing EOs include steam distillation and extraction by 
means of liquid carbon dioxide under low temperature and high pressure. The former 
is commercially used because of the lower cost. The major components of the 
economically interesting EOs are listed in Scheme 2-3. 
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2.3.2 Antibacterial activity of essential oils 
The antibacterial activity of EOs has been tested in vitro for many years. The 
antibacterial efficacies of EOs are commonly characterized by the minimum 
inhibition concentration (MIC) and the minimum bactericidal concentration (MBC). 
Though there are different definitions of these terms, MIC is generally defined as the 
lowest concentration resulting in no visible change in the turbidity of a suspension of 
the test organism for a certain incubation period, while MBC is defined as the 
concentration at which 99.9% or more of the initial inoculum is killed after a certain 
incubation period (Cosentino et al., 1999, Burt, 2004). Table 2-2 summarizes the 
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geraniol carvacrol thymol
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Carvacrol E. coli 0.225-0.5 
(Kim et al., 1995, 
Cosentino et al., 1999)
 S. typhimurium 0.224-0.25 
(Kim et al., 1995, 
Cosentino et al., 1999)
 S. aureus 0.175-0.45 (Cosentino et al., 1999)
 L. monocytogenes 0.375-5 
(Cosentino et al., 1999, 
Kim et al., 1995) 
Eugenol E. coli 1.0 (Kim et al., 1995) 
 S. typhimurium 0.5 (Kim et al., 1995) 
 L. monocytogenes >1.0 (Kim et al., 1995) 
 S. aureus 1.0 (Walsh et al., 2003) 
Geraniol E. coli 0.5 (Kim et al., 1995) 
 S. typhimurium 0.5 (Kim et al., 1995) 
 L. monocytogenes 1 (Kim et al., 1995) 
Thymol E. coli 0.225-0.45 (Cosentino et al., 1999)
 S. typhimurium 0.056 (Cosentino et al., 1999)
 S. aureus 0.140-0.225 (Cosentino et al., 1999)
 L. monocytogenes 0.450 (Cosentino et al., 1999)
 B. cereus 0.450 (Cosentino et al., 1999)
 
2.3.3   Mode of antibacterial action of essential oils 
Although the antimicrobial abilities of EOs have been investigated in many research 
groups, the mechanisms of action are not known in detail. Figure 2-1 shows the 




Figure 2-1 Locations and mechanisms in the bacterial cell thought to be sites of action for EO 
components (Burt, 2004). 
 
It has been proposed that the hydrophobicity of EOs and their components enables 
them to partition in the lipids of the bacterial cell membrane and mitochondria, 
damaging the structures and making them more permeable (Knobloch et al., 1986, 
Sikkema et al., 1994). Consequently, the cell constituents may leak out. The 
continuing leakage would finally result in the death of the cell (Carson et al., 2002). 
Generally, EOs with the strongest antibacterial activities contain a high percentage of 
phenolic compounds, such as eugenol, carvacrol and thymol. Phenolic compounds are 
generally considered to disturb the cytoplasmic membrane, disrupt the proton motive 
force, electron flow, active transport and coagulation of cell contents in bacteria 
(Sikkema et al., 1995, Denyer, 1991, Davidson, 1997). Thus, the phenolic structure of 
EO components may contribute to the antibacterial properties of these compounds. A 
study on the chemical structures of individual EO components showed that the 
presence of hydroxyl group in phenolic compounds such as eugenol, carvacrol and 
thymol has been very important in the action against the bacteria (Dorman and Deans, 
2000). EO components also appear to act on cell proteins embedded in the 
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cytoplasmic membrane, interacting with the enzymes of the bacterial cell, causing 
bacteria death (Knobloch, 1989, Pol et al., 2001). 
 
2.4 Derivatization methods  
Functionalization of existing biomaterials has been studied for many years. The 
requirements for a normal material application always comprise both bulk and surface 
properties.  Thus, the research on the modification of the existing natural materials is 
one of the foci in materials science. Compared to AA and EOs, chitosan is more 
extensively modified to suit various applications in a broad spectrum of areas.  
 
2.4.1 Derivatization of chitosan 
Among the many chitosan derivatives in the literature, one can differentiate between 
specific reactions involving the -NH2 group at the C-2 position or nonspecific 
reactions of hydroxyl (–OH) groups at the C-3 and C-6 positions (especially 
esterification and etherification) (Mourya and Inamdar, 2008). Some simple reactions 
involving C-2 position include the quaternization of the amine group or the reaction 
of an aldehydic functional group with –NH2 by reductive amination. One important 
thing to note is that more regular and reproducible derivatives would be obtained from 
highly deacetylated chitin (Domard and Rinaudo, 1983). Table 2-3 summarizes the 






2.4.2 Derivatization of ascorbic acid 
There has been a great number of works on the chemistry of AA and its derivatives 
(Tolbert, 1975, Andrews and Crawford, 1982). Based on this, many opportunities 
exist for the modification and manipulation of AA. Scheme 2-4 shows the potential 










66-sulfate, acyl, silyl, boryl
and methyl derivatives




boryl and acyl derivatives
5, 6-O-Ketal and acetal derivatives
C-2, C-3 reduction and oxidation
2-sulfate, phosphate, silyl, boryl,
methyl and acyl derivatives2, 3-O-Acetal
derivatives  
Scheme 2-4 Derivatization of L-ascorbic acid at different carbon positions. 
 
L-dehydroascorbic acid (DHA) (shown in Scheme 2-5) is the stable oxidation product 
of AA. Its three carbonyl groups can potentially react with a number of functional 












L-ascorbic acid L-dehydroascorbic acid 
Scheme 2-5 L-ascorbic / L-dehydroascorbic acid interconversion. 
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DHA still possesses reducing ability and can be degradatively oxidized by, for 
example, molecular oxygen and hypoiodite ion to L-threonic and oxalic acids (Davies 
et al., 1991). 
 
2.4.3 Formylation of essential oils 
The formyl group is potentially one of the most useful and versatile functional groups 
to be introduced onto aromatic compounds. The accessibility coupled with versatile 
chemical properties makes aldehydes an important class of organic compounds (Olah 
et al., 1987). As mentioned in Section 2.3, the components of EOs are mostly 
aromatic compounds which can be formylated using proper strategies. 
 
Eugenol, one of the major components of EO, is a phenolic compound. Reports about 
derivatization of eugenol mostly involved the hydroxyl group on the phenolic ring 
(Rahim et al., 2004, Sadeghian et al., 2008, Rojo et al., 2006). In order to preserve the 
hydroxyl group on eugenol, Bhagat et al (1982) synthesized four new derivatives of 
eugenol using halogen and N-bromo-succinimide as halogenating reagents. However, 
the synthesis process required the use of tetrachloroform which is environmentally 
unfriendly. The Reimer-Tiemann reaction may be used to formylate guaiacol to obtain 
vanillin (Divakar et al., 1992). Since the structure of guaiacol is very similar to that of 
eugenol, the Reimer-Tiemann reaction may be used to formylate eugenol to prepare 
eugenol aldehyde. Carvacrol, another important essential oil component, can also be 
formylated and reacted with amines (Knight et al., 2005).  
 
Based on their respective properties, CH, EOs and AA are highly regarded in the 
biological field. With the understanding of their reaction mechanism, strategies can be 
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developed to combine their intriguing properties. The following chapters will show 
how these modification strategies were utilized for preparing chitosan with 
antioxidant and antibacterial properties. 
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3 Antioxidant and antibacterial abilities of chitosan 
ascorbate 
3.1 Introduction 
There is no doubt of the importance of AA. AA, as a popular antioxidant, is 
commonly associated with the treatment of scurvy, once a fatal disease. The ability of 
AA to scavenge free radicals, promote collagen biosynthesis, cause melanin reduction, 
provide photoprotection and enhance immunity, makes it widely applicable in the 
food, cosmetic and pharmaceutical industries (Bossi et al., 2000, Yamamoto et al., 
2002). However, AA is not just an antioxidant. Its remarkable function as a co-
substrate of many important dioxygenases, in regenerating enzymes and its intriguing 
function in gene expression have been reviewed by Arrigoni (2002). 
 
AA was reported to be encapsulated in CH NPs to prevent it from being decomposed 
into inactive compounds (Jang and Lee, 2008, Rojas and Gerschenson, 2001, Yuan 
and Chen, 1998). AA added into chitosan water solution was confirmed to improve 
chitosan solubility and form chitosan ascorbate (Muzzarelli, 1985). Chitosan 
ascorbate was considered to be useful in wound healing process (Pikiel and 
Kopczewski, 1998). Although both the antibacterial and antioxidant properties can 
benefit the wound healing process, there have been no reports on these two properties 
of chitosan ascorbate.  
 
The purpose of this study is to investigate the antibacterial and antioxidant abilities of 
chitosan ascorbate. For this purpose, chitosan ascorbate was first synthesized via the 
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Schiff base reaction. The synthesis product was characterized by XPS and Fourier 
Transform Infrared (FTIR) spectroscopy. The free radical diphenylpicrylhydrazyl 
(DPPH) assay and MIC test were used to evaluate the antioxidant and antibacterial 
activities. Finally, the cytotoxicity of chitosan ascorbate towards 3T3 mouse 





Chitosan was purchased from CarboMer Inc and refined by dissolving in acetic acid 
and followed by filtration.  The viscosity-average molecular weight was about 2.2 
×105 and the degree of deacetylation was 84% as determined by CHN elemental 
analysis.  AA and other chemicals were obtained from Sigma-Aldrich and used as 
received. S. aureus (American Type Culture Collection (ATCC) 25923), E. coli 
(ATCC DH5α) and mouse fibroblast cells (3T3-Swiss albino) were supplied by 
ATCC. 
 
3.2.2 Preparation of chitosan ascorbate 
Chitosan ascorbate (CHAA) was  prepared as reported elsewhere (Muzzarelli et al., 
1984). Briefly, 1 g chitosan powder was suspended in 100 ml of water. Ascorbic acid 
was added (in an amount which is equimolar to the free amino groups of chitosan), 
resulting in the immediate dissolution of chitosan. The resulting light yellow solution 
was limpid and viscous, with pH between 4 and 5. After 6 hours of stirring, the 
solution was precipitated with acetone, and the raw product was dialyzed against 
water for 3 days. The CHAA was obtained after freeze-drying. 
 
3.2.3 Characterization of chitosan ascorbate 
The chemical composition of CHAA was analyzed by XPS on an AXIS HSi 
spectrometer (Kratos Analytical Ltd.) with an AlKα X-ray source (1486.6 eV 
photons). The XPS measurements were carried out as that reported earlier (Shi et al., 
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2005). All binding energies were referenced to the C 1s hydrocarbon peak at 284.6 eV. 
In the peak analysis, the line width (full-width at half-maximum) of the Gaussian peak 
was kept constant for all components in a particular spectrum. FTIR spectra of CH 
and CHAA, dispersed in potassium bromide (KBr) and pelletized, were obtained 
using a Bio-Rad FTIR model FT135 spectrometer under ambient condition. 
 
3.2.4 Free radical scavenging ability of chitosan ascorbate 
Predetermined amounts of the CHAA powder and CH powder were dispersed into 4 
ml of DPPH ethanol solution (0.05 mM) with shaking for 2 hours. The solution was 
then centrifuged and the absorbance of the supernatant was measured at 517 nm. The 
inhibition ratio was expressed as follows: 
Inhibition ratio % = (A0 –AS)/ A0 × 100; 
Where A0 is the absorbance of the DPPH ethanol solution at 517 nm without test 
sample and AS is the absorbance of the supernatant after reaction of DPPH with the 
CH or CHAA. 
 
3.2.5 Antibacterial test of chitosan ascorbate 
The representative gram-positive and gram-negative bacteria (S. aureus and E. coli, 
respectively) were cultured in tryptic soy broth (TSB, Sigma) medium. MIC was 
determined by a turbidimetric method (Andrews, 2001, Qi et al., 2004). In present 
work, since CH is insoluble in water, it was dissolved in culture medium containing 
0.25% (v/v) acetic acid to obtain a stock solution of 8 mg/ml. This solution was 
serially diluted in a 1:1 ratio with broth medium to obtain test sample solutions with 
concentrations ranging from 0.08 mg/ml to 2 mg/ml. The bacteria suspension was 
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then added to each sample solution to achieve a final bacterial concentration of 105 
cells/ml. The bacterial concentration was estimated from the optical density of the 
suspension based on standard calibration with the assumption that the optical density 
of 1.0 at 600 nm for S. aureus suspension is equivalent to approximately 109 cells/ml 
and the optical density of 1.0 at 540 nm for E. coli suspension is equivalent to 
approximately 109 cells/ml. (Shi et al., 2005, Shi et al, 2006).  All the test sample 
solutions were incubated in an orbital shaker with a shaking speed of 200 rpm/min at 
37 °C for 20 hours.  The procedure was repeated with the test sample containing 
CHAA. Solutions of culture medium containing acetic acid ranging from 0 to 
0.0625% (v/v) were used as controls. The preliminary experiment showed the MIC 
value of acetic acid is 0.25% (v/v). The MIC was determined as the minimum 
concentration at which there is no visible change in the turbidity of the medium.  The 
MBC, defined as the lowest concentration of test sample that kills 99.9% of initial 
inoculum, was determined in those test samples after the MIC test showed no growth. 
The assay was carried out by counting the number of colonies after the bacteria were 
cultured overnight on agar plates. 
 
3.2.6 Cytotoxicity assay of chitosan ascorbate 
The MTT assay is a standard colorimetric assay for measuring cellular proliferation 
with the MTT reagent (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
(Mosmann, 1983).  In this work, the 3T3 fibroblasts cells were cultured in a 
supplemented Dulbecco’s Modified Eagle’s Medium (DMEM) (DMEM 90%, fetal 
bovine serum 10%, 1 mM L-glutamine and 100 U/ml penicillin-streptomycin) in a 5% 
CO2 incubator at 37 °C. The CH and CHAA powder were dissolved in 0.25% acetic 
acid solution to prepare the stock solution. Our preliminary experiment showed that 
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0.25% acetic acid did not result in any cytotoxicity effects on the 3T3 mouse 
fibroblasts. 100 μl cell suspension with a concentration of 105 cells/ml was seeded in a 
96-well plate and the plate was incubated for 24 hours.  The medium was then 
substituted with 100 μl medium containing the CH or CHAA at predetermined 
concentrations.  After different periods of incubation, the medium was replaced with 
100 μl medium containing the MTT reagent (0.5 mg/ml).  After 2 hours incubation, 
the medium was removed and the formazan crystals were dissolved with 100 μl 
dimethyl sulfoxide for 15 minutes. The optical absorbance was then measured with a 
microplate reader (Tecan GENios) at a wavelength of 570 nm. Control experiments 




3.3 Results and discussions 
3.3.1 Characterization of chitosan ascorbate 
When the AA was added into the chitosan-water suspension, chitosan dissolved 
rapidly. The AA was oxidized to DHA in water solution and may react with the amine 
groups on chitosan molecules through Schiff base reaction (Muzzarelli, 1985). The 
possible reaction mechanism is shown in Scheme 3-1. The successful modification of 
CH was first confirmed by XPS analysis.  The N 1s core-level spectra of CH and 
CHAA are shown in Figure 3-1.  The N 1s core-level spectrum of CH (Figure 3-1(a)) 
can be fitted with two component peaks at 399.4 eV and 400 eV which are attributed 
to NH and –O=C-N groups. The ratio of –O=C-N to total nitrogen indicates the 
degree of acetylation of chitosan. The degree of acetylation of chitosan calculated 
from Figure 3-1(a) is 15.7%, which is very close to the value of 16% from CHN 
elemental analysis. After modification with AA (Scheme 3-1), two new peaks appears 
at 398.5 eV and 401.6 eV in the N 1s core-level spectrum of CHAA, which can be 
attributed to =N- (Figure 3-1(b)) and N+. The =N- species indicates the formation of 
the Schiff base. On the other hand, the protonated nitrogen may be the result of ionic 
interactions between chitosan and AA in the solution. The degree of acetylation 
calculated from Figure 3-1(b) is 15.2%, which is also consistent with the value 
obtained from elemental analysis of CH. The degree of grafting of AA on CH as 
























































Figure 3-1 XPS N 1s core level spectra of (a) CH and (b) CHAA. 
 
The FTIR spectra of the CH and CHAA are shown in Figure 3-2. The absorption 
bands at 3420 cm-1 and 1078 cm-1 can be attributed to υ(OH) and δ(C-O-C), 
respectively, which are the two characteristic bands of chitosan. After modification, 
an additional band appears at 1720 cm-1, due to the presence of carbonyl groups. 
There is no absorption band at around 1760 cm-1, implying the absence of α-β 
unsaturated cyclic ketones (Muzzarelli, 1984). While absorption bands due to υ(NH) 
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and amide group were observed at about 1656 cm-1 and 1600 cm-1, respectively, for 
CH, a broad absorption band between 1660 cm-1 and 1550 cm-1 was observed for 
CHAA. This is due to the loss of the amine groups in the modification of CH to form 
CHAA, as well as the formation of the C=N group, which has an absorption band at 
around 1640 cm-1.  
 
 
Figure 3-2 FTIR spectra of CH and CHAA. 
 
3.3.2 Free radical scavenging ability of chitosan ascorbate  
The most promising property of AA is its antioxidant activity. Chitosan can be used 
as a wound dressing, as mentioned in Section 2.1.4. CHAA may have the potential to 
be used as wound dressing with enhanced wound healing ability. AA has been 
reported to possess a high antioxidant efficacy with an EC50 (equivalent concentration 
to give 50% effect) value of 5 μg/ml (Kim et al., 2002). The scavenging ability of 
CHAA was compared to CH in Figure 3-3. It can be seen that CHAA shows 
scavenging ability while CH shows almost no scavenging ability. The EC50 value of 




Figure 3-3 Free radical scavenging abilities of CH and CHAA. 
 
3.3.3 Antibacterial test of chitosan ascorbate 
The antibacterial activity of chitosan has been studied thoroughly, as described in 
Chapter 2, while AA has not been reported to have antibacterial activity. The 
antibacterial activity of CH and CHAA were tested using two parameters: MIC and 
MBC. The MIC and MBC values of CH and CHAA against S. aureus and E. coli are 
shown in Table 3-1. The MIC and MBC of CHAA are 0.25 mg/ml while the 
equivalent values for CH against the respective bacteria are generally lower. This 
means that the modification process compromised the antibacterial activity of 
chitosan to some degree. Since the amine groups of chitosan are responsible for the 
antibacterial activity, the reduced activity can be attributed to the consumption of 
some (but not all) of the amine groups in the modification process. However, this 
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effect is compensated by the additional antioxidant properties and the CHAA still 
showed significant antibacterial ability. Wounds are usually accompanied by 
microbial infections and free radicals accumulation which would delay the wound 
healing process  (Houghton et al., 2005). Thus, the confirmed antibacterial ability of 
CHAA, as well as its antioxidant property, would be beneficial the wound healing 
process. With CH or CHAA solution at 0.25 mg/ml, the contribution of acetic acid to 
the killing of the bacteria is minimal as determined from the control experiments. 
 
Table 3-1 MICs and MBCs of CH and CHAA in TSB medium. 
 
MIC (mg/ml) MBC(mg/ml) Sample 
S. aureus E. coli S. aureus E. coli 
CH 0.125 0.032 0.25 0.125 
CHAA 0.25 0.25 0.25 0.25 
 
3.3.4 Cytotoxicity assay of chitosan ascorbate 
AA has been reported to have cytotoxic effects under certain conditions. It has been 
shown to be cytotoxic to several types of normal and tumor cells in vitro (Bram et al., 
1980, Jampel, 1990). The cytotoxicity is believed to be dependent on the cell density 
and AA concentration. With 105 human skin fibroblasts cells/well, a concentration of 
0.1 mM (17.6 μg/ml) AA resulted in 66% cell viability (Murakami et al., 1992). Our 
experiment showed that AA would cause death of 3T3 mouse fibroblast cells above a 
concentration of 20 μg/ml. The MTT results of CH and CHAA towards 3T3 
fibroblasts are shown in Figure 5-4. It can be seen that the cells incubated with CHAA 
grew better than those incubated with CH. At concentrations close to the MIC values 
of CHAA for S. aureus and E. coli, the fibroblast viability is about 105%. When the 
concentration increases to 0.5 mg/ml, the fibroblast viability is still above 100%. Thus, 
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by grafting AA to chitosan, antibacterial and antioxidant properties can be achieved 
with reduced mammalian cell cytotoxicity as compared to AA.  
 
Figure 3-4 Viabilities of 3T3 fibroblasts (105 cells/ml) incubated with CH and CHAA dissolved in 
the culture medium containing 0.25% acetic acid for 72 hours. The viabilities are expressed as 





In this section, the synthesis of chitosan ascorbate (CHAA) was demonstrated. The in 
vitro DPPH assay and MIC test confirmed that CHAA possesses both free radical 
scavenging ability and antibacterial property while chitosan only has antibacterial 
property. The antibacterial efficacy of CHAA against E. coli and S. aureus is lower 
than that of CH because of the consumption of some amine groups on chitosan during 
the grafting process. Nevertheless, CHAA still possesses significant antibacterial 
efficacy with an MIC value of 0.25 mg/ml against both bacteria. The decrease in 
antibacterial activity is compensated by additional antioxidant ability. The 
modification also decreases the cytotoxicity of CHAA compared to AA. Since the 
grafting reaction takes place between the amine groups of chitosan and ascorbic acid, 





4 Antioxidant and antibacterial activities of eugenol 
grafted chitosan nanoparticles 
4.1 Introduction    
Eugenol, as a major component of EOs, is an aromatic compound extracted from 
clove, nutmeg and cinnamon.  It has been widely used in food, dentistry and cosmetic 
industries because of its antibacterial, antifungal and antioxidant properties (Kalemba 
and Kunicka, 2003, Burt, 2004, Bakkali et al., 2008). Eugenol is one of ingredients of 
zinc oxide eugenol cement (ZOE), which has been widely used in dentistry for 
indirect pulp capping, and also as a temporary filling and root canal sealer (Markowitz 
et al., 1992). Eugenol’s antimicrobial activity may be the result of its hydrophobicity 
and hydroxyl group. The hydrophobicity of eugenol may enable it to partition in the 
lipids of bacterial cell membrane and mitochondria, damaging the structures and 
making cell membrane more permeable (Knobloch et al., 1986). The hydroxyl group 
is thought to bind to proteins, thus preventing enzyme action (Wendakoon and 
Sakaguchi, 1993).  
 
Eugenol has been reported to be a highly effective antioxidant (Ogata et al., 2000, 
Atsumi et al., 2005, Mastelic et al., 2008) at low concentration, while it act as a 
prooxidant at high concentration, causing tissue damage due to the formation of 
harmful phenoxyl radicals (Decker, 1997, Suzuki et al., 1985). The antioxidant 
potency of eugenol probably depends on its aromatic chemical structure, where the 
electrons are delocalized on the aromatic nucleus (Kitagawa et al., 1992). 
Recently, eugenol’s ability to inhibit cancer cell growth was reported as well 
(Carrasco et al., 2008, Pisano et al., 2007). However, it has also been reported that 
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eugenol irritates periapical tissue, and may have some degree of toxicity (Manabe et 
al., 1987). For instance, eugenol caused a depression of cell membrane surface tension 
at the concentration of 0.1 mM resulting in rat hepatocytes membrane lysis (Manabe 
et al., 1987). 
 
 In present study, we investigated the combination of two natural compounds, eugenol 
and chitosan, to obtain a product with antibacterial and antioxidant properties and yet 
low cytotoxicity. Eugenol was first modified with aldehyde groups and then reacted 
with chitosan and chitosan nanoparticles through the Schiff base reaction. The 
antioxidant and antibacterial activities of eugenol grafted chitosan were assayed, and 





Sodium tripolyphosphate (TPP) and eugenol (98%) was obtained from Sigma-Aldrich 
and used as received.  The S. aureus, E. coli and fibroblasts were obtained from 
ATCC as mentioned in Chapter 3. 
 
4.2.2 Synthesis of eugenol aldehyde 
A general Reimer-Tiemann reaction was used to synthesize eugenol aldehyde 
(Divakar et al., 1992). 22 mmol eugenol was dissolved in 150 ml water at 80 ºC.  
After bringing down the temperature of the mixture to 60 ºC, 400 mmol KOH and 88 
mmol chloroform were added.  The latter was added at a rate of 1 ml per hour over a 
period of 7 hours. The reaction mixture was kept at 60 ºC for another 8 hours. Post-
treatment was initiated with the acidification of the solution with dilute sulfuric acid, 
and eugenol aldehyde was recovered by extraction with methylethyl ketone.    
 
4.2.3  Preparation of chitosan nanoparticles 
A general ionic gelation method was used to prepare chitosan nanoparticles (CH NPs) 
(Zhang et al., 2004, Shi et al., 2006).  The procedure was as follows: 0.5% (w/v) 
chitosan in 1% (v/v) acetic acid solution was adjusted to pH of about 4.1 with 10 N 
sodium hydroxide. 10 ml of 2.5 mg/ml TPP solution was then added dropwise into 30 
ml of chitosan solution with stirring at 1000 rpm for 15 min. The nanoparticles were 
then separated by centrifugation at 15000 rpm for 30 min.  The supernatant was 
removed and the CH NPs were rinsed with water followed by freeze-drying. 
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4.2.4 Grafting of eugenol on chitosan and chitosan nanoparticles 
through the Schiff base reaction 
The Schiff base reaction was used for grafting the eugenol aldehyde onto the CH 
powder and CH NPs. A 100 ml round bottom flask with stirrer was charged with 30 
ml methanol and 100 mg CH powder or CH NPs, followed by addition of an excess 
amount of eugenol aldehyde (based on the amount of amine group in chitosan).  The 
reaction mixture was refluxed for 48 hours.  The eugenol grafted CH (CHEU) or 
eugenol grafted CH NPs (CHEU NPs) were obtained by centrifugation at 15000 rpm 
after washing with ethanol several times and drying in a vacuum oven at 40 ºC for 12 
hours.  
 
4.2.5 Characterization techniques 
The UV-visible absorption characterization of the synthesized eugenol aldehyde was 
investigated using a Shimadzu UV-3101 PC scanning spectrophotometer. 1H NMR 
spectra were measured on a Bruker ARX 300 MHz spectrometer, using deuterated 
chloroform as the solvent. The chemical composition of CHEU and CHEU NPs were 
analyzed by XPS. The detailed process was described in Section 3.2.3. FTIR spectrum 
of CHEU and CHEU NPs was obtained as described in Section 3.2.3. 
 
The nanoparticles were examined using a field-emission scanning electron 
microscope (FE-SEM, JEOL JSM 6700F) under the TEM mode. The particle sizes 
and zeta potentials of CH NPs and CHEU NPs were measured using a Zetasizer Nano 
ZS (Malvern Instruments, Southborough MA) with a laser of 633 nm wavelength at a 
90º scattering angle.  The suspensions containing the different nanoparticles were 
prepared with Mili-Q water. The mixture was vortexed for 30 s before the 
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measurement was conducted.  The size measurement was conducted at 25°C in 
triplicate.  The zeta potential measurement was performed using a capillary zeta 
potential cell in automatic mode in triplicate and the average values were reported.  
 
4.2.6 Scavenging ability of eugenol grafted chitosan derivatives 
The scavenging abilities of CHEU, CH, CHEU NPs and CH NPs were measured and 
expressed as described in Section 3.2.4. 
 
4.2.7 Determination of antibacterial activity of eugenol grafted chitosan 
derivatives 
For the antibacterial assay, the stock solutions of CH and CHEU were prepared by 
dissolving them in broth medium containing 0.25% (v/v) acetic acid due to their 
insolubility in the water. These test samples were then diluted to obtain a series of 
concentrations, as described in Section 3.2.5. On the other hand, the CH NPs and 
CHEU NPs were directly dispersed in broth medium. The rest of the procedures are as 
described in Section 3.2.5. 
 
4.2.8 In vitro cytotoxicity of eugenol grafted chitosan derivatives 
The MTT assay was utilized to investigate the cytotoxicity of CHEU and CHEU NPs 
towards 3T3 mouse fibroblasts. The stock solutions of CH and CHEU were prepared 
by dissolving them in culture medium containing 0.25% acetic acid. The solution 
without CH or CHEU was used as controls. The bulk solution was then diluted to 
form a series of concentrations as described in Section 3.2.6. On the other hand, the 
CH NPs and CHEU NPs were directly dispersed in the cell culture medium, and the 
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medium without the nanoparticles was used as control. The rest of the procedures are 




4.3 Results and discussions  
4.3.1 Synthesis of eugenol aldehyde 
The UV-visible absorption spectra of phenolic aldehydes indicate a peak at around 
310 nm due to n-π* transition of the keto group, and another at around 275 nm 
attributed to π- π* transition of the phenolic portion (Divakar et al., 1992). Therefore, 
UV-visible absorption spectroscopy can provide direct evidence for the successful 
synthesis of eugenol aldehyde. The UV-visible absorption spectra of eugenol before 
and after formylation are compared in Figure 4-1. The peak at 282 nm is characteristic 
of the phenolic group of eugenol. After formylation of eugenol, the appearance of two 
peaks at 311 nm and 350 nm indicates the formation of a mixture of phenolic 
aldehyde groups. 
 
Figure 4-1 UV-visible absorption spectra of eugenol before and after formylation. 
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From 1H NMR analysis of the eugenol before and after formylation, three new signals 
are observed in the eugenol aldehyde products: 10.97 ppm for the ortho-aldehyde, 
9.88 ppm and 9.84 ppm for two forms of meta-eugenol aldehyde (Divakar et al., 
1992). From the UV-visible absorption spectroscopy and NMR analysis, the possible 
synthesis products from eugenol are given in Scheme 4-1.  The low NMR signal of 
one of the meta-eugenol aldehydes indicates its low concentration relative to the 
ortho- and the other meta-aldehyde products and hence its presence was not 
discernible from the UV-visible absorption spectrum in Figure 4-1(b). The product 
yield of eugenol aldehydes as estimated from the 1H NMR spectra, was about 20%.  
Our preliminary experiments showed that eugenol did not react with the chitosan 
powder or chitosan nanoparticles.  Hence, the grafting reactions with chitosan powder 
or chitosan nanoparticles were carried out using the eugenol aldehydes without the 

















Scheme 4-1 Synthesis products of eugenol aldehydes: 1) eugenol; 2) 2-hydroxyl-3-methoxy-5-(2-




4.3.2 Characterization of eugenol grafted chitosan derivatives 
Jung and coworkers (2006) prepared eugenol-grafted chitosan hydrogels by grafting 
eugenol to chitosan via cerium (IV) ammonium nitrate mediated polymerization.  
Their DPPH assay showed that the hydrogel possessed antioxidant activity. In our 
work, eugenol aldehyde was grafted to chitosan and chitosan nanoparticles through 
Schiff base reaction (Knight et al., 2005).  The successful modifications of CH and 
CH NPs were first confirmed by XPS analysis.  The N 1s core-level spectra of CH, 
CH NPs, CHEU and CHEU NPs are shown in Figure 4-2.  The N 1s core-level 
spectrum of CH (Figure 4-2(a)) is the same as that shown in Chapter 3. For CH NPs 
(Fig 4-2(b)), an additional high binding energy (BE) peak (above 400 eV) is observed 
and attributed to the positively charged nitrogen (N+), which may be the result of 
ionic interaction with TPP during the nanoparticle preparation process.  After Schiff 
base reaction (Scheme 4-2), a new peak appears at 398.5 eV in the N 1s core-level 
spectra of CHEU and CHEU NPs, which is attributed to =N- (Figure 4-2(c)). The 
degree of grafting of eugenol on CH NPs is calculated from the ratio of =N- to the 
total nitrogen. The degree of acetylation of chitosan and the degree of grafting of 
eugenol as determined from the XPS analysis are summarized in Table 4-1. Under the 
same reaction conditions, the degree of grafting of eugenol on chitosan is half of that 
on CH NPs. The higher degree of grafting of the latter is likely to be the result of the 
increased surface area of the nanoparticles. As expected, the grafting of eugenol did 













5)CH or CH NPs grafted with 2: a=OH, b=OCH3, c=H, d=2-propenyl,e=H;
6)CH or CH NPs grafted with 3: a=H, b=OH, c=OCH3, d=H, e=2-propenyl;
7)CH or CH NPs grafted with 4: a=2-propenyl, b=H, c=H, d=OH, e=OCH3;
 




Table 4-1 Degree of acetylation of chitosan before and after grafting with eugenol and the degree 
of grafting. 
 
 Degree of acetylation Degree of grafting of 
eugenol 
CH 15.7% --- 
CH NPs 16.2% --- 
CHEU 15.7% 12.0% 











Figure 4-2 XPS N 1s core-level spectra of (a) chitosan (CH); (b) chitosan nanoparticles (CH NPs); 
(c) eugenol grafted chitosan (CHEU); (d) eugenol modified chitosan nanoparticles (CHEU NPs). 
 
 
Figure 4-3 FTIR spectra of CH, CHEU, CH NPs and CHEU NPs. 
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The FTIR spectra of the CH, CHEU, CH NPs and CHEU NPs are shown in Figure 4-
3.   The characteristic band at 3400 cm-1 corresponds to the combined peaks of the -
NH2 and -OH group stretching vibration in chitosan. The two absorption bands at 
1650 cm-1 and 1592 cm-1 attributed to υ(C=O) and υ(NH), characteristic of chitosan, 
are shifted to 1637 cm-1 and 1540 cm-1, respectively, after nanoparticles formation 
(Knaul et al., 1999). The polyphosphoric groups of sodium polyphosphate may 
interact with the ammonium groups of chitosan, enhancing both the inter- and intra-
molecular interactions between chitosan nanoparticles, resulting in the shift of the 
υ(C=O) and υ(NH) absorption bands. After the Schiff base reaction, the intensity ratio 
of the υ(NH) band at 1540 cm-1 to the υ(C=O) band at 1637 cm-1 in the spectrum of 
CHEU NPs decreased in comparison to the corresponding ratio of CH NPs. A similar 
effect was observed when the spectra of CH and CHEU were compared. This 
decrease arises as amine groups on the surfaces of CH NPs and CH powder are 
consumed in the formation of –C=N- groups. 
 
Table 4-2 shows the size and zeta potential of CH NPs and CHEU NPs.  The average 
hydrodynamic diameter of CH NPs and CHEU NPs were determined to be 217 nm 
and 235 nm, respectively.  The average size of CH NPs (Figure 4-4(a)) and CHEU 
NPs (Figure 4-4(b)) from TEM pictures are both around 100 nm. The larger size 
determined by the Zetasizer is probably due to the different measurement 
environment. The NPs are suspended in water when measured by the Zetasizer, but 
under the vacuum environment of the TEM, the NPs lose water, causing them to 
shrink. As expected, there is no substantial change in the size of the nanoparticles 
after grafting with eugenol.  As shown in Table 4-2, the zeta potential of CHEU NPs 











 resulted from the consumption of amine groups in the Schiff base reaction. It will be 
shown in Section 4.3.4 that this decrease in zeta potential does not compromise the 
antibacterial action of CHEU NPs. 
 
Table 4-2 Characteristics of CH NPs and CHEU NPs. 
 
NPs Hydrodynamic size (nm) Polydispersity Zeta potential (mV) 
CH NPs 217±17 0.595 +37.6±1.3 
CHEU NPs 235±12 0.318 +28.4±2.2 
 
4.3.3 Free radical scavenging ability of eugenol grafted chitosan 
derivatives 
The process of wound healing includes inflammation, cell proliferation and 
contraction of collagen lattice formation. When a wound is incurred, it is 
accompanied, within a short time by pain, reddening and edema, which are the typical 
symptoms of inflammation caused by the release of eicosanoids, prostaglandins, 
leukotrienes and ROS (Sidhu et al., 1999, Houghton et al., 2005).  These oxygen-
derived species consist of oxygen radicals and certain non-radicals that are oxidizing 
agents and/or are easily converted into radicals.  Antioxidants have been shown to 
play a role in delaying or preventing oxidative stress caused by free radicals (Hermans 
et al., 2007).  Chitosan is widely used in wound healing, because it enhances the 
functions of inflammatory cells such as polymorphonuclear leukocytes, macrophages 
and fibroblasts; consequently, it promotes granulation and the organization phase of 
healing (Minagawa et al., 2007, Ueno et al., 2001, Degim, 2008).  Conferring chitosan 
with eugenol ligands may retain its favorable biological properties for wound healing 




It has been reported that eugenol exhibits high free radical scavenging ability with 
EC50  values of about 9 μg/ml (Mastelic et al., 2008).  The free-radical scavenging 
ability of CHEU and CHEU NPs are compared to CH and CH NPs, respectively, in 
Figure 4-5. It can be seen that both CHEU and CHEU NPs show free radical 
scavenging ability dependent on their concentrations in the range of from 0.25 mg/ml 
to 4 mg/ml. The EC50 value for CHEU is above 4 mg/ml while the EC50 of CHEU 
NPs is 2.6 mg/ml (Figure 4-5). The nanoparticle form of CH improved the reaction 
condition and increased the degree of grafting of eugenol, resulting in a higher 
antioxidant efficacy. As a control, the CH and CH NPs showed nearly no free radical 
scavenging ability. Although some researchers have reported the limited antioxidant 
properties of chitosan nanoparticles, their antioxidant activity largely depends on the 
molecular weight and degree of deacetylation (Je and Kim, 2006, Xing et al., 2005a). 
 
4.3.4    Antibacterial effects of eugenol grafted chitosan derivatives 
The mechanisms of the antibacterial action of CH have not been fully understood, it is 
believed that the interactions between the protonated amine units of CH and the 
negatively charged cell membrane leads to disruption of the membrane functions and 
leakage of cellular components (Raafat et al., 2008). During the antibacterial test, 
chitosan was used as the control to compare with CHEU while the CH NPs acted as 
the control for CHEU NPs. The MICs and MBCs of CH, CHEU, CH NPs and CHEU 
NPs against S. aureus and E. coli are shown in Table 4-3. It can be seen that the MIC 
and MBC values of CHEU are higher than those of CH, indicating that CHEU is less 
effective as an antibacterial agent compared to CH. With CHEU at 0.5 mg/ml, the 
contribution of acetic acid in the killing of bacteria is still very limited according to 




Figure 4-5  Free radical scavenging abilities of (a) CHEU and CH; (b) CH NPs and CHEU NPs. 
 
both gram-positive and gram-negative bacteria than CH NPs, indicating that the 
modification of CH NP by eugenol did not result in loss of antibacterial efficacy. As 
can be seen from Scheme 4-2, the modification of CH NPs with eugenol via the Schiff 
base reaction involves the amine group of CH. Thus, it might be expected that the 
antibacterial properties of the CH will be compromised. However, eugenol is also 
known to have antibacterial properties (Kim et al., 1995, Cosentino et al., 1999). The 
free hydroxyl group on benzene ring is essential for the antimicrobial ability of 
eugenol (Wendakoon and Sakaguchi, 1993, Ben Arfa et al., 2006), and since this 
group is not affected by the modification process, the phenolic group may compensate 
for the “lost” antibacterial properties of the amine group on CH NPs.  As for CHEU, 
the grafting of eugenol rendered it less soluble even in acetic acid solution, which 
significantly decreased the probability of its interaction with bacteria, thus lowering 
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the antibacterial efficacy when compared to chitosan. However, the CHEU NPs are 
able to penetrate into cell membrane due to their small sizes, resulting in the death of 
the bacterial cells. As a result, the CHEU NPs showed improved antibacterial efficacy 
compared to CH NPs, even though CHEU showed lower antibacterial efficacy 
compared to CH. 
 
At the site of a wound, ROS is produced in high amounts as a defense mechanism 
against invading bacteria.  However, the process of wound healing may also be 
hampered by the presence of free radicals which can damage the cells surrounding the 
wound or by microbial infections (Houghton et al., 2005).  The DPPH and 
antibacterial assays have confirmed that the CHEU NPs possess both antioxidant and 
antibacterial properties.  Thus, such NPs with dual functionalities may have good 
potential for enhancing wound healing. 
 
Table 4-3 MICs and MBCs of chitosan and eugenol grafted chitosan derivatives in TSB medium 
against S. aureus and E. coli. 
 
S. aureus E. coli Polymer 
MIC (mg/ml) MBC (mg/ml) MIC (mg/ml) MBC (mg/ml) 
CH 0.125 0.25 0.032 0.125 
CHEU 0.5 0.5 0.125 0.25 
CH NPs 0.5—1 2 0.5—1 2 
CHEU NPs 0.5 1 0.25—0.5 2 
 
4.3.5  Cytotoxicity assay of eugenol grafted chitosan derivatives 
Since the ultimate goal of our research is the application of the antioxidant and 
antibacterial chitosan derivatives in mammalian systems, the issue of cytotoxicity has 
to be addressed. Pure eugenol has been reported to be toxic and the cytotoxicity value 
(defined as the maximum concentration not resulting in death) of eugenol on human 
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gingival fibroblasts is 1.9 μM (0.31 μg/ml) (Gerosa et al., 1996).  Our results also 
show that the cytotoxicity value of eugenol on 3T3 mouse fibroblasts is 0.31μg/ml. 
Figure 4-6(a) shows the viabilities of the 3T3 mouse fibroblasts incubated with CH 
and CHEU. There is no significantly cytotoxicity for CHEU below 0.1 mg/ml. When 
the concentration increases to 0.5 mg/ml (MIC value of CHEU against S. aureus), the 
cell viability drops to 60%. There is no cytotoxic effect observed for CH. In fact, CH 
even promotes cell growth in this experiment. 
 
Figure 4-6(b) shows the viabilities of the 3T3 mouse fibroblasts when incubated with 
CH NPs and CHEU NPs of various concentrations. There is no significant 
cytotoxicity when the concentrations of CH NPs and CHEU NPs are below 0.2 mg/ml.  
When the NPs concentrations are increased to 0.5 mg/ml which is close to the MIC 
values of both CH NPs and CHEU NPs (except for CH NPs against E. coli where the 
value is 0.125 mg/ml), the cell viability decreases to 92% for CHEU NPs but 
remained at 100% for CH NPs. With further increase in NPs concentration to 1 mg/ml, 
significant cytotoxicity (< 50% viability) is observed with CHEU NPs.  However, 
with CH NPs at a concentration of 2 mg/ml, the cell viability is still higher than 80%.  
 
The advantages of the CHEU over eugenol can be seen by comparing their respective 
MIC against bacteria and the cytotoxicity values for 3T3 mouse fibroblasts. The MICs 
of eugenol against both S. aureus and E. coli are 1 mg/ml (Kim et al., 1995, Cosentino 
et al., 1999). Since the cytotoxicity value of eugenol towards 3T3 mouse fibroblast is 
0.31 μg/ml, the application of eugenol at their MIC values against bacteria would 
result in the killing of mammalian cells as well. On the other hand, the cell viability of 
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3T3 fibroblasts is 60% for CHEU and 92% for CHEU NPs, respectively, at their MIC 
value (0.5 mg/ml). 
 
 
Figure 4-6 Viabilities of 3T3 mouse fibroblasts incubated with (a) CH and CHEU dissolved in 
culture medium containing 0.25% acidic acid; (b) CH NPs and CHEU NPs dispersed in the 




In this work, chitosan and chitosan nanoparticles were successfully grafted with the 
essential oil component, eugenol. The grafting was facilitated by first converting the 
eugenol to its aldehydes. The in vitro DPPH assay and MIC test confirmed that the 
chitosan and chitosan nanoparticles grafted with eugenol possessed both antioxidant 
and antibacterial activities whereas the unmodified chitosan only have antibacterial 
properties. Most importantly, the antibacterial efficacy of the eugenol grafted chitosan 
nanoparticles against S. aureus (gram-positive bacterium) and E. coli (gram-negative 
bacterium) is just as high as or even better than the unmodified chitosan nanoparticles. 
The eugenol-grafted chitosan nanoparticles are significantly less cytotoxic towards 
mammalian cells than free eugenol. At the MIC of the former (against S. aureus and E. 
coli), fibroblasts still exhibit >90% viability whereas at the MIC of the pure eugenol, 
the fibroblasts will no longer be viable. The successful modification of chitosan with 
eugenol provides the incentive for similar modifications with other members of the 
essential oil family. In the next chapter, another essential oil component, carvacrol, 




5 Antioxidant and antibacterial activities of carvacrol 
grafted chitosan nanoparticles 
5.1 Introduction 
Natural antioxidants have been extensively studied for their ability to protect 
organisms and cells from being damaged by ROS (Cozzi et al., 1997, Gordon and 
Weng, 1992, Kim et al., 1994). Herbs are harmless sources of natural antioxidants. 
Carvacrol is one of the essential oil components which can be extracted from thyme. 
It has been reported to possess antimicrobial and antioxidant properties. Recently, 
carvacrol was also reported to have the ability to inhibit cancer cell growth (Seval and 
Yusuf, 2006, Koparal and Zeytinoglu, 2002). However, carvacrol may have some 
degree of toxicity (Bimczok et al., 2008). For instance, carvacrol inhibited the 
proliferation of purified porcine lymphocytes with an IC50 (half maximum inhibitory 
concentration) of 182 ± 67 μM in MTT assays (Bimczok et al., 2008).   
 
 In this section, carvacrol was grafted to chitosan to obtain nanoparticles with 
antibacterial and antioxidant properties and yet relative low cytotoxicity. Carvacrol 
was modified with aldehyde groups and then reacted with chitosan nanoparticles 
through the Schiff base reaction. The antioxidant and antibacterial activities of these 
nanoparticles were assayed, and the cytotoxicity towards mouse 3T3 fibroblasts was 





The chitosan and TPP were the same as described in Chapter 4. Carvacrol (98%) were 
obtained from Sigma-Aldrich and used as received.  Acetonitrile, triethylamine, 
anhydrous magnesium chloride (MgCl2) and paraformaldehyde were also purchased 
from Sigma-Aldrich. S. aureus, E. coli and mouse fibroblast cells were supplied by 
ATCC. 
 
5.2.2 Synthesis of carvacrol aldehyde 
The synthesis of carvacrol aldehyde was performed under a moisture free 
environment using the method described in an earlier work (Knight et al., 2005). In 
this method carvacrol was formylated selectively at the position ortho to the hydroxyl 
group. Briefly, a 250 ml round bottom flask was placed under an argon atmosphere 
and filled with 40 mmol carvacrol, 150 ml acetonitrile, 150 mmol triethylamine and 
40 mmol anhydrous MgCl2.  The solution was stirred for 15 min at room temperature. 
270 mmol paraformaldehyde was then added, and the reaction mixture was refluxed 
for 3.5 h. The solution was then allowed to cool to room temperature and acidified by 
the addition of 5% (w/v) aqueous hydrochloric acid (320ml) followed by stirring for 
30 min under argon atmosphere.  The product was extracted by diethyl ether and the 
ether portion was collected and washed with saturated sodium chloride aqueous 
solution.  The volatiles were removed under reduced pressure to yield the raw 




5.2.3 Preparation of chitosan nanoparticles 
A general ionic gelation method was used to prepare chitosan nanoparticles (CH NPs) 
(Shi et al., 2006).  The details were described in Section 4.2.3. CH NPs prepared as 
described in the previous chapter were used for grafting with carvacrol. 
 
5.2.4 Grafting of carvacrol on chitosan nanoparticles through the Schiff 
base reaction 
Carvacrol grafted chitosan nanoparticles (CHCA NPs) were synthesized using the 
same method as described in Section 4.2.4, with the use of carvacrol aldehyde in 
place of eugenol aldehyde. 
 
5.2.5 Characterization techniques 
The as-synthesized carvacrol aldehyde was characterized by UV-visible spectroscopy 
and 1H NMR, as described in Section 4.2.5. The CHCA NPs were characterized by 
XPS and FTIR, as described in Section 3.2.3 and 4.2.5. The particle size and zeta 
potential of the CHCA NPs were determined as described in Section 4.2.5. 
 
5.2.6 Scavenging ability of carvacrol grafted chitosan nanoparticles  
The scavenging ability of CHCA NPs was measured and expressed using the method 
as described in Section 3.2.4. 
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5.2.7 Determination of antibacterial activity of carvacrol grafted 
chitosan nanoparticles 
The antibacterial efficacy of CHCA NPs was determined in the same manner as that 
described in Section 4.2.7 for CHEU NPs. 
 
5.2.8 In vitro cytotoxicity of carvacrol grafted chitosan nanoparticles 
The MTT assay, as described in Section 4.2.8, was used to investigate the cytotoxic 
effect of CHCA NPs. 
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5.3 Results and discussions  
5.3.1 Synthesis of carvacrol aldehyde  
As mentioned in Section 4.3.1, the two peaks at 310 nm and 275 nm of the UV-visible 
absorption spectra are the two characteristic peaks of phenolic aldehydes. Hence, UV-
visible absorption spectroscopy was used to characterize the synthesis product of 
carvacrol. The UV-visible absorption spectra of carvacrol before and after 
formylation are compared in Figure 5-1. The peak at 276 nm is characteristic of the 
phenolic groups of carvacrol. After formylation of carvacrol, a new absorption peak at 
350 nm appears indicating the formation of phenolic aldehyde. 






















Figure 5-1 UV-visible absorption spectra of carvacrol before and after formylation. 
 
The 1H NMR analysis of the carvacrol before and after formylation showed an 
additional peak at 10.42 ppm for carvacrol aldehyde as compared to carvacrol (Knight 
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et al., 2005). From the UV-visible absorption spectroscopy and NMR analysis, the 
possible synthesis product from carvacrol is given in Scheme 5-1. The product yield 
of carvacrol aldehyde estimated from the 1H NMR spectra is 51.7%.  Our preliminary 
experiments showed that carvacrol does not react with the chitosan nanoparticles.  
Hence, the grafting reactions with chitosan nanoparticles were carried out using the 







Scheme 5-1 Synthesis process of carvacrol aldehyde. 
 
5.3.2 Characterization of carvacrol grafted chitosan nanoparticles 
In the present work, the Schiff base reaction was chosen for grafting carvacrol to 
chitosan nanoparticles due to the ease of synthesis and structural rigidity  of Schiff 
base (Knight et al., 2005).  The successful modification of the CH NPs was first 
confirmed by XPS analysis.  The N 1s core-level spectrum of CHCA NPs is shown in 
Figure 5-2. Comparing this spectrum to that of CH NPs in Figure 4-2(b), a new 
component peak appears at about 398.5 eV in the N 1s core-level spectrum of CHCA 
NPs, attributed to =N- species formed after Schiff base reaction (Scheme 5-2). The 
degree of acetylation of chitosan and the degree of grafting of carvacrol, as calculated 
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from the XPS analysis, are summarized in Table 5-1. As expected, the degree of 
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Table 5-1 Degree of acetylation of chitosan before and after grafted with carvacrol and the 
degree of grafting. 
 
 Degree of acetylation Degree of grafting of 
carvacrol 
CH 15.7% --- 
CH NPs 16.2% --- 





Figure 5-2 XPS N 1s core-level spectrum of CHCA NPs. 
 
The FTIR spectra of the CH NPs and CHCA NPs are shown in Figure 5-3.  The 
absorption band at 3400 cm-1 is attributed to -OH and -NH2 stretching vibration in the 
chitosan matrix (Xu and Du, 2003).  The absorption bands at 1637 cm-1 and 1540 cm-1 
attributed to υ(C=O) and υ(NH), respectively, are characteristic bands of chitosan 
nanoparticles (Knaul et al., 1999). After the formylation reaction, the intensity ratio of 
the υ(NH) band at 1540 cm-1 to the υ(C=O) band at 1637 cm-1 in the spectrum of 
CHCA NPs decreased compared to the corresponding ratio in the spectrum of CH 
NPs. This decrease is due to the consumption of amine groups on the CH NPs surface 




Figure 5-3 FTIR spectra of CH NPs and CHCA NPs. 
 
In the ionic gelation method, the nanoparticles were formed through interactions 
between the positively charged chitosan and negatively charged phosphate groups of 
TPP.  Table 5-2 shows the sizes and zeta potentials of CH NPs and CHCA NPs.  The 
average hydrodynamic diameter of CHCA NPs was determined to be 260 nm, 
compared to 217 nm for CH NPs.  The TEM images of CH NPs (Figure 4-4(a)) and 
CHCA NPs (Figure 5-4) show that both the average sizes of CH NPs and CHCA NPs 
are around 100 nm. The size difference may originate from the different measurement 
techniques, as explained in Section 4.3.2. As expected, there is no substantial change 
in the size of the nanoparticles after grafting with the carvacrol and there seems to be 
no agglomeration. The zeta potential of the particle surface plays an important role in 
the surface interactions as mentioned in Section 4.3.2. As shown in Table 5-2, the zeta 
potential of CHCA NPs is lower than that of CH NPs. This decrease may result from 
the consumption of the amine groups of the CH NPs in the Schiff base reaction. It will 
Chapter 5 
 67
be shown in Section 5.3.4 that this decrease in zeta potential does not compromise the 
antibacterial action of the carvacrol-grafted CH NPs. 
 
Table 5-2 Characteristics of CH NPs and CHCA NPs 
 
NPs Hydrodynamic size (nm) Polydispersity Zeta potential (mV) 
CH NPs 217±17 0.595 +37.6±1.3 
CHCA NPs 260±18 0.366 +18.8±1.0 
 
 
Figure 5-4 TEM investigation of CHCA NPs. The scale bar is 1 μm. 
 
5.3.3 Free radical scavenging ability of carvacrol grafted chitosan 
nanoparticles 
Conferring chitosan with carvacrol ligand may retain its favorable biological 
properties for wound healing while providing promising antioxidant activity to 
accelerate the wound healing process, as mentioned in Section 4.3.3. It has been 
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reported that carvacrol exhibits free radical scavenging ability with EC50 values of 
about 267 μg/ml (Mastelic et al., 2008).  The free radical scavenging ability of CHCA 
NPs is shown in Figure 5-5. It can be seen that CHCA NPs show free radical 
scavenging ability dependent on the concentration in the range of 0.25 mg/ml to 4 
mg/ml. The EC50 value for CHCA NPs is slightly higher than 4.0 mg/ml. 
 
Figure 5-5 Free radical scavenging abilities of CH NPs and CHCA NPs. 
 
5.3.4 Antibacterial effects of carvacrol grafted chitosan nanoparticles 
The antibacterial effect of CHCA NPs was evaluated using two parameters: MIC and 
MBC.  The MICs and MBCs of CHCA NPs against S. aureus and E. coli are shown in 
Table 5-3. It can be seen that the MICs and MBCs of CHCA NPs and CH NPs are 
similar against both gram-positive S. aureus and gram-negative E. coli, indicating that 
the modification of CH NPs by carvacrol did not result in any loss of antibacterial 
efficacy. As discussed earlier, the modification of CH NPs with carvacrol via the 
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Schiff base reaction, similar to eugenol grafting process, also involved the amine 
group and the zeta potential of the CH NPs decreased after grafting with the EO 
components. Thus, this may result in the loss of the antibacterial efficacy. However, 
like eugenol, carvacrol is also known to have antibacterial properties (Kim et al., 1995, 
Cosentino et al., 1999). The free hydroxyl group on the benzene ring is essential for 
the antimicrobial activity of carvacrol (Wendakoon and Sakaguchi, 1993, Ben Arfa et 
al., 2006), and since this group is not influenced by the reaction, the phenol group 
may compensate for the “lost” antibacterial properties of the reacted amine group on 
CH NPs.  As a result, the CHCA NPs showed almost the same antibacterial efficacy 
as CH NPs. 
 
Table 5-3 MICs and MBCs of CH NPs and CHCA NPs in TSB medium against S. aureus and E. 
coli. 
 
S. aureus E. coli NPs 
MIC (mg/ml) MBC (mg/ml) MIC (mg/ml) MBC (mg/ml) 
CH NPs 0.5—1 2 0.5—1 2 
CHCA NPs 0.5—1 2 0.5—1 2 
 
As mentioned in Section 2.1.4, chitosan has been applied in wound healing process. 
The DPPH and antibacterial assays have confirmed that CHCA NPs possess both 
antioxidant and antibacterial properties, which would be advantageous for scavenging 
the free radicals and killing bacteria at the wound site. This would promote the wound 
healing process by preventing ROS-caused cell damages and microbial infection. 
 
5.3.5  Cytotoxicity assay of carvacrol grafted chitosan nanoparticles 
If CHCA NPs are intended for clinic use, their cytotoxic effect towards mammalian 
cells should be addressed. Pure carvacrol has been reported to be toxic (Bimczok et al., 
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2008). Our results also show that the cytotoxicity value of carvacrol on 3T3 mouse 
fibroblasts is 0.28 μg/ml. Figure 5-6 compares the viabilities of the 3T3 mouse 
fibroblasts when incubated with CH NPs and CHCA NPs of various concentrations. 
Similar to the results observed with CHEU NPs, there is no significant cytotoxicity 
when the concentration of CHCA NPs is below 0.2 mg/ml.  When the NPs 
concentration is increased to 0.5 mg/ml (close to the MIC of CHCA NPs), the cell 
viability decreases to 81%. With further increase in NPs concentration to 1 mg/ml, 
significant cytotoxicity (< 50% viability) is observed with CHCA NPs.   
 
Figure 5-6 Viabilities of 3T3 mouse fibroblasts incubated with CH NPs and CHCA NPs 
distributed in the culture medium for 72 hours. 
 
The advantages of the CHCA NPs over pure carvacrol can be seen by comparing their 
respective MIC against bacteria and the cytotoxicity values for 3T3 mouse fibroblasts. 
The MICs of carvacrol against S. aureus and E. coli are 0.175—0.45 mg/ml and 
0.225—0.5 mg/ml, respectively (Kim et al., 1995, Cosentino et al., 1999). Since the 
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cytotoxicity value of carvacrol towards 3T3 mouse fibroblast is 0.28 μg/ml, the 
application of carvacrol at their MIC values against bacteria would result in the killing 




5.4 Comparative study of carvacrol grafted chitosan 
nanoparticles and eugenol grafted chitosan nanoparticles 
5.4.1 Degree of grafting of essential oil components 
The successful modification of chitosan nanoparticles with the two essential oil 
components, eugenol and carvacrol, was confirmed by the XPS. Under the same 
reaction condition (excess essential oil aldehyde compared to the amine groups on the 
CH NPs), the degree of grafting of carvacrol is 50.7% (Figure 5-2) while the degree 
of grafting of eugenol is 26.7% (Figure 4-2). The degree of grafting of carvacrol  is 
twice that of eugenol. A possible reason is that the -OCH3 group on eugenol aldehyde 
causes steric hindrance during the Schiff base reaction.  
 
5.4.2 Antibacterial activity 
The antibacterial activities of CHEU NPs and CHCA NPs were conducted in the same 
batches. The results have been shown in Table 4-3 and Table 5-3. It can be seen that 
the antibacterial efficacy of CHEU NPs is higher than that of CHCA NPs, while the 
antibacterial efficacy of CHCA NPs is similar to that of CH NPs. The amine groups of 
chitosan and the hydroxyl groups on the aromatic rings of eugenol and carvacrol are 
believed to be responsible for the antibacterial properties. Though the Schiff base 
reaction compromised some of the amine groups on the chitosan, the grafted essential 
oil component contains hydroxyl groups that were preserved. Since the exact 
mechanisms of antibacterial activities of chitosan and essential oils are still unknown, 
it is not possible to draw a conclusion regarding the relative antibacterial efficacy of 
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the amine group versus that of the hydroxyl group on the aromatic ring of eugenol and 
carvacrol. 
    
5.4.3 Antioxidant activity 
The free radical scavenging efficacy of pure eugenol has been reported to be 30 times 
higher than that of pure carvacrol (Mastelic et al., 2008). The hydroxyl groups on 
their aromatic rings are probably responsible for the antioxidant activity. Since the 
modification process did not compromise the hydroxyl groups on their aromatic rings, 
a higher free radical scavenging ability of CHEU NPs as compared to that of CHCA 
NPs is expected, and this is confirmed by comparing the DPPH assays in Figure 4-5 
and Figure 5-5. The EC50 value for CHEU NPs is nearly twice that of CHCA NPs 
even though the degree of grafting of essential oil component for CHEU NPs is only 
half that for CHCA NPs. Though the modification process did not involve the 
hydroxyl groups on the aromatic rings of carvacrol and eugenol, the introduction of 
aldehyde groups linked to the amine groups of chitosan may influence the free radical 
scavenging action. 
 
5.4.4 Cytotoxicity  
Pure eugenol and carvacrol are cytotoxic with very similar cytotoxicity values. The 
grafting of eugenol and carvacrol onto chitosan nanoparticles lowers the cytotoxicity 
of CHEU NPs and CHCA NPs, compared to pure eugenol and carvacrol, respectively. 
At the MIC of CHEU NPs (0.25 – 0.5 mg/ml), the cell viability of 3T3 mouse 
fibroblasts is still above 90%, while at the MIC of CHCA NPs (0.5 – 1 mg/ml), the 
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cell viability decreased to 80% or even 50%. The CHEU NPs seem to have lower 





In this work, chitosan nanoparticles were successfully grafted with the essential oil 
component, carvacrol. The grafting was facilitated by first converting carvacrol to 
carvacrol aldehyde. The in vitro DPPH assay and MIC test confirmed that the CHCA 
NPs possessed both antioxidant and antibacterial activities whereas the chitosan 
nanoparticles have only antibacterial properties. The antibacterial efficacies of CHCA 
NPs against S. aureus (gram-positive bacterium) and E. coli (gram-negative bacterium) 
are very close to those of the unmodified CH NPs. The CHCA NPs are significantly 
less cytotoxic towards mammalian cells than free carvacrol. At the MIC of the former 
(against S. aureus and E. coli), fibroblasts will exhibit >50% viability whereas at the 
MIC of the pure carvacrol, the fibroblasts will be no longer viable.  
 
When the antioxidant activities and antibacterial activities of CHCA NPs were 
compared to those of CHEU NPs, the use of CHEU NPs is more advantageous than 
CHCA NPs because of their higher antioxidant and antibacterial efficacies and lower 
cytotoxicity. In addition, CHEU NPs may have potential applications in dentistry, 




6 Conclusion and recommendations 
6.1 Conclusion 
Three natural materials have been modified to develop dual functional properties: 
antioxidant and antibacterial. Chitosan was utilized as the bulk material to be 
modified with functional biomaterials, ascorbic acid (AA) and essential oils (EOs), 
through the Schiff base reaction. Biological assessments of the functionalized systems 
have been designed to evaluate their performances in vitro. The results are shown in 
Table 6-1. 
  
Table 6-1 Comparison of chitosan modified with essential oil component and ascorbic acid 
Antibacterial Activity 










S. aureus E. coli S. aureus E. coli 
CH -- Nil 0.125 0.032 0.25 0.125 
CH NPs -- Nil 0.5—1 0.5—1 2 2 
CHAA 15.2% 3.6 0.25 0.25 0.25 0.25 
CHEU 12% >4.0 0.5 0.125 0.5 0.25 
CHEU NPs 26.7% 2.6 0.5 0.25—0.5 1 2 
CHCA NPs 50.7% >4.0 0.5—1 0.5—1 2 2 
Nil: DPPH tests have shown nearly no free radical scavenging ability. 
--: Not applicable 
 
First of all, AA was reacted with chitosan to prepare chitosan ascorbate (CHAA). The 
biological assessments confirmed that chitosan attained the additional free radical 
scavenging ability after modification with AA, although the modification caused a 




Considering that phenolic aldehyde formed Schiff base should be more stable than 
CHAA, the aldehyde group was introduced onto the aromatic ring of eugenol, a 
component of essential oils, and the as-synthesized eugenol aldehyde was reacted 
with chitosan and chitosan nanoparticles (CH NPs) through Schiff base reaction to 
yield eugenol-grafted chitosan (CHEU) and eugenol-grafted chitosan nanoparticles 
(CHEU NPs), respectively. The degrees of grafting of eugenol were calculated from 
XPS analysis to be 12.0% and 26.7% for CHEU and CHEU NPs, respectively. The 
properties of CHEU NPs were found to be superior to those of CHEU. The 
immobilized eugenol was found to confer antioxidant ability on CH NPs with an EC50 
value of 2.6 mg/ml.  On the other hand, the existing antibacterial property of CH NPs 
was not compromised although the modification process consumed amine groups. At 
the MIC of CHEU NPs against S. aureus and E. coli, the cell viability of 3T3 mouse 
fibroblasts can be as high as 92%. On the other hand, pure eugenol at its MIC against 
the same bacteria would result in mammalian cell death. 
 
Finally, the modification strategy was extended to another essential oil component, 
carvacrol. Aldehyde groups were first introduced on the aromatic ring of carvacrol. 
The carvacrol-grafted chitosan nanoparticles (CHCA NPs) were then obtained by 
coupling the aldehyde groups on carvacrol aldehyde to the amine groups on CH NPs. 
The biological assessments confirmed that the CHCA NPs simultaneously possess 
antioxidant and antibacterial abilities, with lower cytotoxicity than pure carvacrol. A 
comparison made between CHEU NPs and CHCA NPs showed that CHEU NPs, with 
only about half the degree of grafting of the essential oil component as CHCA NPs, 
have twice the antioxidant activity. The CHEU NPs exhibited higher antibacterial 
efficacy than CH NPs and CHCA NPs. With such excellent biological properties, the 
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CHEU NPs still possess lower cytotoxicity than CHCA NPs, thus less damage 





A number of possible applications of modified chitosan with antibacterial and 
antioxidant activities can be foreseen. Two examples which need further study are 
given below: 
 
Influence of degree of deacetylation on antioxidant and antibacterial properties 
of eugenol and carvacrol grafted chitosan  
In this thesis, chitosan with 84% degree of deacetylation has been used so that the 
results obtained can be more easily compared with our previous work. As mentioned 
in Section 2.1.2, previous studies have shown that the degree of deacetylation has a 
strong correlation with the antioxidant and antibacterial properties. So, similar 
modifications of chitosan of different degree of deacetylation with the essential oils 
and ascorbic acid should be carried out. 
 
Chitosan nanoparticulate system as a carrier to deliver growth factor for wound 
healing 
 Growth factors, such as epidermal growth factor (EGF) and fibroblast growth factor 
(FGF), can be encapsulated in CHEU NPs or CHCA NPs. With this encapsulation 
system, the release behavior of growth factor can be investigated, and the in vivo 
wound healing effect can be studied. This antibacterial and antioxidant 
nanoparticulate system may be an effective delivery vehicle for pharmaceutical 
purposes.  
 
Essential oil component-grafted chitosan film for food packaging 
Chapter 6 
 80
Effective food packaging should possess moisture prevention, ROS and bacteria 
inhibition properties in addition to the appropriate mechanical property. Since the 
essential oil component-grafted chitosan nanoparticles have been confirmed to 
possess antibacterial and antioxidant properties and the modification technique is 
applicable to chitosan film, the use of essential oil component-grafted chitosan film 
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